Ivana Z. Boljevic
Belgrade, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Validation of LOH-Germline Inference Calculator of Variant Origin on Real-World Data of Prevalence of Germline and Somatic BRCA1/2 Mutations in High-Grade Serous Ovarian Cancer in Serbia.
Journal: JCO precision oncology
Published: May 28, 2026
EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: January 17, 2021
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals.
Journal: Expert review of molecular diagnostics
Published: December 07, 2020
Expression levels of genes involved in cell adhesion and motility correlate with poor clinicopathological features of epithelial ovarian cancer.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: October 25, 2020
Discovery of the Biginelli hybrids as novel caspase-9 activators in apoptotic machines: Lipophilicity, molecular docking study, influence on angiogenesis gene and miR-21 expression levels.
Journal: Bioorganic chemistry
Published: November 02, 2018
TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool.
Journal: Journal of clinical pathology
Published: October 16, 2018
Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia.
Journal: Journal of human genetics
Published: September 07, 2018
Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.
Journal: Familial cancer
Published: July 08, 2017
Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: November 13, 2016
Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
Journal: Cancer biomarkers : section A of Disease markers
Published: September 26, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026